Bio Techne Corp Stock Price Prediction

TECH Stock  USD 74.41  0.28  0.37%   
As of 13th of November 2024, the relative strength index (RSI) of Bio Techne's share price is approaching 43. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Bio Techne, making its price go up or down.

Oversold Vs Overbought

43

 
Oversold
 
Overbought
The successful prediction of Bio Techne's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Bio Techne Corp, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Bio Techne's stock price prediction:
Quarterly Earnings Growth
(0.32)
EPS Estimate Next Quarter
0.38
EPS Estimate Current Year
1.78
EPS Estimate Next Year
2.02
Wall Street Target Price
85.4
Using Bio Techne hype-based prediction, you can estimate the value of Bio Techne Corp from the perspective of Bio Techne response to recently generated media hype and the effects of current headlines on its competitors.

Bio Techne Corp Hype to Price Pattern

Investor biases related to Bio Techne's public news can be used to forecast risks associated with an investment in Bio. The trend in average sentiment can be used to explain how an investor holding Bio can time the market purely based on public headlines and social activities around Bio Techne Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Bio Techne's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Bio Techne.
The fear of missing out, i.e., FOMO, can cause potential investors in Bio Techne to buy its stock at a price that has no basis in reality. In that case, they are not buying Bio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Bio Techne after-hype prediction price

    
  USD 74.43  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Bio Techne Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Techne's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
66.9787.6889.78
Details
Naive
Forecast
LowNextHigh
73.3575.4577.55
Details
15 Analysts
Consensus
LowTargetHigh
91.91101.00112.11
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.360.390.40
Details

Bio Techne After-Hype Price Prediction Density Analysis

As far as predicting the price of Bio Techne at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bio Techne or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bio Techne, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Bio Techne Estimiated After-Hype Price Volatility

In the context of predicting Bio Techne's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bio Techne's historical news coverage. Bio Techne's after-hype downside and upside margins for the prediction period are 72.33 and 76.53, respectively. We have considered Bio Techne's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
74.41
74.43
After-hype Price
76.53
Upside
Bio Techne is very steady at this time. Analysis and calculation of next after-hype price of Bio Techne Corp is based on 3 months time horizon.

Bio Techne Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Bio Techne is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bio Techne backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bio Techne, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.01 
2.10
  0.02 
 0.00  
9 Events / Month
12 Events / Month
In about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
74.41
74.43
0.03 
103.96  
Notes

Bio Techne Hype Timeline

Bio Techne Corp is at this time traded for 74.41. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of 0.0. Bio is forecasted to increase in value after the next headline, with the price projected to jump to 74.43 or above. The average volatility of media hype impact on the company the price is about 103.96%. The price growth on the next news is projected to be 0.03%, whereas the daily expected return is at this time at 0.01%. The volatility of related hype on Bio Techne is about 1243.42%, with the expected price after the next announcement by competition of 74.41. The company reported the previous year's revenue of 1.16 B. Net Income was 168.07 M with profit before overhead, payroll, taxes, and interest of 770.22 M. Given the investment horizon of 90 days the next forecasted press release will be in about 9 days.
Check out Bio Techne Basic Forecasting Models to cross-verify your projections.

Bio Techne Related Hype Analysis

Having access to credible news sources related to Bio Techne's direct competition is more important than ever and may enhance your ability to predict Bio Techne's future price movements. Getting to know how Bio Techne's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bio Techne may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
BMRNBiomarin Pharmaceutical(0.79)11 per month 0.00 (0.23) 1.77 (2.75) 21.32 
PCVXVaxcyte(0.06)11 per month 1.78  0.06  3.16 (2.84) 42.81 
LQDALiquidia Technologies 0.02 11 per month 0.00 (0.05) 3.96 (4.24) 39.46 
LEGNLegend Biotech Corp(0.98)8 per month 0.00 (0.21) 3.66 (5.82) 17.18 
SGENSeagen Inc 0.00 0 per month 0.00 (0.23) 1.02 (0.89) 6.86 
ALNYAlnylam Pharmaceuticals 0.95 10 per month 2.14 (0.07) 2.85 (3.39) 12.61 
EXELExelixis 0.69 9 per month 0.90  0.12  3.14 (1.77) 13.08 
HALOHalozyme Therapeutics 0.13 9 per month 2.61 (0.01) 3.25 (4.12) 14.63 
REPLReplimune Group 0.02 7 per month 2.98  0.08  7.23 (5.60) 15.63 
NUVLNuvalent(0.97)10 per month 2.57  0.06  4.64 (4.61) 36.85 
VTYXVentyx Biosciences(0.18)7 per month 3.04  0.01  6.88 (5.86) 22.25 
ASNDAscendis Pharma AS(6.90)9 per month 2.63 (0.04) 4.75 (3.13) 22.16 
UTHRUnited Therapeutics 2.82 11 per month 1.27  0.07  3.04 (2.33) 13.37 
APLSApellis Pharmaceuticals 0.67 8 per month 0.00 (0.17) 4.00 (4.00) 15.97 
BGNEBeiGene 2.11 7 per month 2.50 (0.05) 3.10 (4.40) 13.85 
AKROAkero Therapeutics(0.22)8 per month 2.35  0.11  5.23 (4.24) 11.85 
BPMCBlueprint Medicines Corp(0.56)8 per month 2.24 (0.04) 3.92 (3.25) 9.44 
TVTXTravere Therapeutics 0.21 12 per month 1.93  0.24  11.58 (4.13) 23.97 

Bio Techne Additional Predictive Modules

Most predictive techniques to examine Bio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bio using various technical indicators. When you analyze Bio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Bio Techne Predictive Indicators

The successful prediction of Bio Techne stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bio Techne Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bio Techne based on analysis of Bio Techne hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bio Techne's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bio Techne's related companies.
 2021 2022 2023 2024 (projected)
Dividend Yield0.0036910.0039190.0044640.004241
Price To Sales Ratio12.311.299.746.9

Story Coverage note for Bio Techne

The number of cover stories for Bio Techne depends on current market conditions and Bio Techne's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bio Techne is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bio Techne's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Bio Techne Short Properties

Bio Techne's future price predictability will typically decrease when Bio Techne's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bio Techne Corp often depends not only on the future outlook of the potential Bio Techne's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bio Techne's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding160.8 M
Cash And Short Term Investments152.9 M

Complementary Tools for Bio Stock analysis

When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
CEOs Directory
Screen CEOs from public companies around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine